CHRS

Coherus BioSciences, Inc.

1.86 USD
-0.02 (-1.06%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Coherus BioSciences, Inc. stock is down -10.14% since 30 days ago. The next earnings date is Jul 31, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 9 May’s closed higher than April. In the last 1 Unusual Options Trades, there were 1 CALL. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
03 May 19:57 17 Jan, 2025 2.00 CALL 250 1831

About Coherus BioSciences, Inc.

Coherus BioSciences, Inc. markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor. Pipeline products include biosimilars of Humira, Avastin, and Lucentis. Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma in China.

  • HC Wainwright & Co.
    Fri May 24, 06:23
    buy
    confirm
  • Truist Securities
    Mon May 13, 08:18
    buy
    confirm
  • HC Wainwright & Co.
    Fri May 10, 15:35
    buy
    confirm